信诺集团(Cigna)
CI
302.30
+3.49
+1.17%
信诺集团(Cigna)
US · CI
#312 按市值排名
上市于 1970
302.30
+3.49
+1.17%
实时 - 追踪5344个代码 - 心跳于335秒前
· 2026-10-16 20:02
✦ 量化股权信号 计算方式说明
减持
- 最近一期(2026/Q3)披露持股的机构数量减少了12家。
- 机构持股总比例下降了0.2个百分点。
机构持股
- 机构持股比例
- 92.76% -0.20pp
- 机构数量
- 1,989 -12
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份,同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。
持股人类型
Mutual Fund79.27%
Hedge Fund3.63%
Public Company3.30%
Government Pension Fund2.36%
Private Company1.70%
Sovereign Wealth Fund1.50%
Insurance Company0.40%
Individual/Insider0.38%
Family Office/Trust0.24%
Other7.22%
主要股东 截至 2026-06-30
BlackRock
8.87% · 23.44M 股
Vanguard Capital Management, LLC
7.10% · 18.76M 股
State Street Global Advisors
4.80% · 12.68M 股
Dodge & Cox
4.61% · 12.17M 股
MFS Investment Management
3.95% · 10.44M 股
Other
70.67%
Sanders Capital, LLC
3.84% · 10.14M 股
Geode Capital Management, LLC
2.37% · 6.27M 股
Vanguard Portfolio Management, LLC
2.36% · 6.23M 股
GQG Partners, LLC
2.24% · 5.91M 股
FMR
2.10% · 5.55M 股
条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 24次买入 · 14次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| David Cordani | President, CEO & Chair of the Board | 0.25% |
| Brian Evanko | President | 0.03% |
| Eric Foss | Independent Director | 0.01% |
| Jason Sadler | President of International Markets | 0.01% |
| Eric Palmer | President & CEO of Evernorth | 0.01% |
| Nicole Jones | Executive Vice President | 0.01% |
| William DeLaney | Independent Director | 0.01% |
| David Brailer | Executive VP & Chief Health Officer | 0.01% |
| Adam Kautzner | President of Evernorth Care Management & Express Scripts & Evernorth Health Services | 0.01% |
| Matt Perlberg | President, Pharmacy & Care Delivery at Evernorth Health Services | 0.00% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-02 | F. Neville | Executive Vice President of Strategy, Corporate Development & Solutions | Automatic Disposition | -617 | $284.05 |
| 2026-08-31 | Brian Evanko | President | Other Acquisition | +3,113 | -- |
| 2026-08-31 | Brian Evanko | President | Other Derivative Acquisition | +6,716 | $281.13 |
| 2026-08-30 | George Kurian | Independent Director | Other Derivative Acquisition | +108 | -- |
| 2026-08-17 | Nicole Jones | Executive Vice President | Automatic Disposition | -2,677 | $279.61 |
| 2026-08-05 | Bryan Holgerson | Chief Underwriting Officer of U.S. Commercial | Other Derivative Acquisition | +2 | -- |
| 2026-08-04 | Nicole Jones | Executive Vice President | Derivative Exercise and Retained | +1,301 | $192.02 |
| 2026-08-03 | Nicole Jones | Executive Vice President | Automatic Disposition | -5,391 | $276.27 |
| 2026-08-03 | Nicole Jones | Executive Vice President | Derivative Exercise and Sale | -14,045 | $192.02–276.27 |
| 2026-06-30 | Jason Sadler | President of International Markets | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Bryan Holgerson | Chief Underwriting Officer of U.S. Commercial | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Paul Sanford | Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Adam Kautzner | President of Evernorth Care Management & Express Scripts & Evernorth Health Services | Initial Statement of Beneficial | 0 | -- |
| 2026-06-30 | Matt Perlberg | President, Pharmacy & Care Delivery at Evernorth Health Services | Initial Statement of Beneficial | 0 | -- |
| 2026-06-11 | Jamie Kates | Chief Accounting Officer | Derivative Exercise and Sale | -899 | $152.89–298.61 |
| 2026-05-31 | Durga Koka | Executive Vice President & Global Chief Information Officer | Sale to Issuer | -729 | $275.53 |
| 2026-05-28 | George Kurian | Independent Director | Other Derivative Acquisition | +108 | -- |
| 2026-05-12 | David Cordani | President, CEO & Chair of the Board | Derivative Exercise and Retained | +23,429 | $149.14–197.35 |
| 2026-05-11 | David Cordani | President, CEO & Chair of the Board | Automatic Disposition | -12,764 | $298.24–298.53 |
| 2026-05-11 | David Cordani | President, CEO & Chair of the Board | Derivative Exercise and Sale | -189,114 | $149.14–298.24 |
Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 20:02:33 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
信诺集团(Cigna) 讨论区 0 条评论